Found 1 resultsAuthor Title Type [ Year]
Filters: Author is Chuenarom, Weerawan [Clear All Filters]
The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope. J Immunol, 188(10), 5166-76. presented at the 2012 May 15. doi:10.4049/jimmunol.1102756. (2012).